Barclays' diversified business mix, international reach, and strategic initiatives position it for continued growth. Read why ...

Relay Therapeutics, Inc. (NASDAQ:RLAY) is one of the best strong buy penny stocks to buy now. In a report released on July 29 ...

Barclays is transforming into a more profitable, shareholder-focused bank, targeting a sustainable RoTE above 12% by 2026.

Gena Wang of Barclays kept BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) at a Buy rating with a price target of $86.00 in a report published on June 10.

June 19, 2025 — 12:00 pm EDT Written by Zacks Equity Research for Zacks -> Barclays (BCS) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy).

Finally, Guggenheim decreased their target price on Target from $155.00 to $115.00 and set a “buy” rating for the company in a research note on Tuesday, May 27th.

On July 3, Barclays raised the firm’s price target on Hewlett Packard Enterprise Company (NYSE:HPE) from $24 to $26, while keeping an overweight rating on the stock.